Hims & Hers Health (HIMS) Depreciation & Amortization (CF) (2020 - 2026)

Hims & Hers Health (HIMS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $22.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 165.26% year-over-year to $22.0 million; the trailing twelve-month figure through Mar 2026 stood at $56.1 million (up 172.06% YoY), and the FY2025 full-year result was $54.5 million, up 218.95% from the prior year.
• Depreciation & Amortization (CF) advanced to $22.0 million in Q1 2026, from $18.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $22.0 million in Q1 2026 to a low of $900000.0 in Q3 2022.
• A 5-year average of $5.5 million and a median of $2.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Peak annual rise in Depreciation & Amortization (CF) reached 341.88% in 2022, while the deepest fall reached 41.79% in 2022.
• Tracing HIMS's Depreciation & Amortization (CF) over 5 years: stood at $2.0 million in 2022, then jumped by 32.24% to $2.7 million in 2023, then soared by 128.03% to $6.1 million in 2024, then jumped by 198.5% to $18.1 million in 2025, then climbed by 21.34% to $22.0 million in 2026.
• Business Quant data shows HIMS's Depreciation & Amortization (CF) at $22.0 million in Q1 2026, $18.1 million in Q4 2025, and $8.5 million in Q3 2025.